Clinical Trials Browser

Phase 3 × INDUSTRY × Neutropenia × Clear all

NCT04174599 2025-04-20

Study to Compare the Efficacy and Safety of F-627 and GRAN®

Phase 3 Completed

242 enrolled 41 charts

Breast Neoplasms, Neutropenia

NCT03252431 2023-07-03

Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Phase 3 Completed

393 enrolled 20 charts

Breast Neoplasms, Neutropenia

NCT02643420 2022-03-02

ADVANCE

Phase 3 Completed

406 enrolled 19 charts

Breast Neoplasms, Neutropenia

NCT02953340 2022-03-02

SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide

Phase 3 Completed

237 enrolled 18 charts

Breast Neoplasms, Neutropenia

NCT02467868 2022-02-14

Efficacy and Safety Study With MYL-1401H and Neulasta

Phase 3 Completed

BreastClassical hematology

Breast Neoplasms, Neutropenia, Chemotherapy-Induced Febrile Neutropenia

NCT04466137 2022-02-09

Phase 3 Study to Evaluate the Safety and Efficacy of YPEG-rhG-CSF in Malignancies Receiving Chemotherapy

Phase 3 Completed

Classical hematology

Neutropenia, Febrile Neutropenia

NCT02872103 2021-05-05

Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Phase 3 Completed

122 enrolled 19 charts

Breast Neoplasms, Neutropenia

NCT03343145 2020-12-28

A Study to Evaluate the Efficacy, Safety and Immunogenicity of Leucostim® Versus Neupogen® in Breast Cancer Patients

Phase 3 Completed

Breast Neoplasms, Neutropenia

NCT03404752 2018-01-19

Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients.

Phase 3 Unknown

Breast Neoplasms, Neutropenia

NCT00911170 2017-12-29

PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

Phase 3 Completed

847 enrolled 21 charts

Classical hematologyGastrointestinal

Colonic Neoplasms, Fever, Neoplasms, Neutropenia, Rectal Neoplasms, Colorectal Neoplasms, Febrile Neutropenia

NCT01516736 2017-08-30

PROTECT2

Phase 3 Completed

308 enrolled 19 charts

Breast Neoplasms, Neutropenia

NCT01735175 2017-08-07

PROTECT-1

Phase 3 Completed

316 enrolled 20 charts

Breast Neoplasms, Neutropenia

NCT00044486 2017-03-10

Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899)

Phase 3 Completed

MyeloidOther hematologic neoplasm

Mycoses, Myelodysplastic Syndromes, Neutropenia, Leukemia, Myeloid, Acute

NCT02104830 2016-10-24

Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients

Phase 3 Completed

135 enrolled 18 charts

BreastClassical hematology

Breast Neoplasms, Neutropenia, Febrile Neutropenia

NCT01519700 2015-05-06

PIONEER

Phase 3 Completed

218 enrolled 15 charts

Breast Neoplasms, Neutropenia

NCT00035594 2013-05-09

Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy

Phase 3 Completed

Breast Neoplasms, Neutropenia

NCT01611051 2013-01-08

A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy

Phase 3 Completed

BreastClassical hematology

Breast Neoplasms, Neutropenia, Febrile Neutropenia

NCT01560195 2012-11-06

A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy

Phase 3 Unknown

Classical hematology

Neutropenia, Febrile Neutropenia

NCT00529282 2012-08-01

A Study of Ceftobiprole in Patients With Fever and Neutropenia.

Phase 3 Terminated

2 enrolled 4 charts

Fever, Neutropenia, Pseudomonas Infections, Gram-Positive Bacterial Infections

NCT00117910 2008-05-16

Treatment for Elderly Patients With High Risk Breast Cancer

Phase 3 Completed

Breast Neoplasms, Neutropenia

NCT00002277 2005-06-24

A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections

Phase 3 Completed

Mycoses, Neoplasms, Neutropenia, HIV Infections